Thank You! Scott Dye Memorial Topgolf Tournament

May 17, 2021

The Scott Dye Memorial Topgolf Tournament took place on Saturday, May 8, 2021, at Topgolf in Glendale, Arizona.  The event was held to memorialize a great man by raising awareness and research funding for esophageal cancer by supporting The Salgi Esophageal Cancer Research Foundation. 

Scott Dye Memorial Topgolf Tournament

On behalf of The Salgi Esophageal Cancer Research Foundation, we would like to thank everyone who supported The Scott Dye Memorial Top Golf Tournament and give a special thank you to the Dye Family for putting together such a wonderful event.

Thank you in-kind sponsors:

Nothing Bundt Cakes

The Tifin Group

Great Clips

Thank you also to family and friends of the Dye Family for donating gift baskets to the event!

Linda, Michelle, Jennifer and Richard coordinated the event in memory of Scott E. Dye, who passed away from stage IV esophageal cancer on December 13th, 2015.  This is their story:

“It seems like just yesterday that we found out our father was diagnosed with esophageal cancer. Our father went to the hospital for chest pain on November 13, 2015 and after the CAT scan was completed, the doctors found a mass on his liver. That is when his primary doctor did more tests (endoscopy) and blood work. The results came back indicating esophageal cancer, Stage IV, on November 30, 2015.  Once the cancer was known, there was nothing but vomiting, nausea and dehydration that came from it in the coming days and weeks. We were watching him quickly go downhill just days after he was diagnosed. During this time, a port was put in so that chemotherapy could start and the goal was to FIGHT and beat this nightmare.

By December 9, 2015, he was transported back to the hospital due to a stomach hemorrhage. He was clinging to his life as his kidneys started to fail. Our father was placed in ICU and was too weak to start his chemotherapy. This was all happening too fast and we could not process that he was diagnosed with cancer, let alone that he passed away on December 13, 2015, just a month after symptoms and a diagnosis was given. To see someone you love pass away in front of your eyes is the most unexplainable feeling you can have and you will remember it forever.

We wanted to find a way to help with funding and research. So we have teamed up with The Salgi Esophageal Cancer Research Foundation as a way to raise awareness and remember our father and to help others become aware of symptoms and early detection of cancer.”

To view more photos from the event, please click here.


Fundraising Spotlight: In Loving Memory of Scott Dutra, Northeast Barbers Raising Money during April, Esophageal Cancer Awareness Month.

April 16, 2021

Will Lima is the owner of Northeast Barbers in West Warwick, Rhode Island. He and his wife, Karey, are hosting a fundraiser throughout the month of April at the barbershop for The Salgi Esophageal Cancer Research Foundation.  Karey’s father, Scott Dutra, passed away from esophageal cancer in 2017. Karey has shared his story below:

Scott (dad) was diagnosed with esophageal cancer on November 23, 2015.  As devastating as this diagnosis was, dad was optimistic that he would overcome this disease with the care of his doctor and with the love and support of his children and family.  We thought he would have his surgery then go home and have a 2nd chance at life but unfortunately cancer had another plan for him. 

Over the next 18 months, Dad would continue to spend most of time in the hospital due to complications.  At one point, he was able to spend time with my brother and me at home, eating, laughing, and enjoying his life again.  On December 26, 2016 we received the news that the cancer was back, and my dad had up to a year left with us.  Dad was able to spend a couple more weeks at home with us but unfortunately, he ended up back in the hospital

My dad passed away on January 24, 2017 and as difficult as it was to lose him; it was equally a blessing because while he fought to the very end he suffered terribly.  He is and will be missed every day of our lives.  We hope we make you proud, we love you, dad XOXO.

Northeast Barbers is located at 1191 Main St, West Warwick, RI 02893, (401) 390-4228. You can follow Will on his Instagram page here: https://www.instagram.com/limathebarber

Please join us in thanking Will and Karey by sharing this fundraiser and post with your family members, friends and on social media.  Thank you!

Facebook: https://www.facebook.com/SalgiFoundation


FDA Approves First Immunotherapy for Initial Treatment of Gastric, Esophageal Cancers

April 16, 2021

The following is based on a press release provided by the U.S. Food and Drug Administration.

Image via: Shutterstock

“Today, the U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemotherapy, for the initial treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma. This is the first FDA-approved immunotherapy for the first-line treatment of gastric cancer.

“Today’s approval is the first treatment in more than a decade to show a survival benefit for patients with advanced or metastatic gastric cancer who are being treated for the first time,” said Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in the FDA’s Center for Drug Evaluation and Research. “The FDA is committed to bringing new safe and effective treatment options like Opdivo to patients with advanced cancer.”

In 2021, an estimated 19,260 will be diagnosed with esophageal cancer and there will be an estimated 15,530 deaths from esophageal cancer.¹ The five-year survival rate for all stages of esophageal cancer is 19.9%. Gastric cancer also carries similar, concerning statistics.

“There are approximately 28,000 new diagnoses of gastric cancer each year in the U.S. With currently available therapy, overall survival is generally poor; the rate of cure with resection is very low and the survival rate for all stages is 32%. The 5-year survival rate for advanced or metastatic gastric cancer is 5%.With currently available therapy, overall survival is generally poor; the rate of cure with resection is very low and The 5-year survival rate for advanced or metastatic gastric cancer is 5%.

Opdivo is a monoclonal antibody that inhibits tumor growth by enhancing T-cell function. Its efficacy was evaluated in a randomized, multicenter, open-label trial of 1,581 patients with previously untreated advanced or metastatic gastric cancer, gastroesophageal junction cancer and esophageal adenocarcinoma. The 789 patients who received Opdivo in combination with chemotherapy, on average, lived longer than the 792 patients who received chemotherapy alone. Median survival was 13.8 months for patients who received Opdivo plus chemotherapy compared to 11.6 months for patients who received chemotherapy alone.

The most common side effects of Opdivo in combination with chemotherapy include peripheral neuropathy (damage to the nerves outside of the brain and spinal cord), nausea, fatigue, diarrhea, vomiting, decreased appetite, abdominal pain, constipation and musculoskeletal pain. Opdivo can cause serious conditions known as immune-mediated side effects, including inflammation of healthy organs such as the lungs (pneumonitis), colon (colitis), liver (hepatitis), endocrine glands (endocrinopathies) and kidneys (nephritis). Patients should tell their healthcare providers if they have immune system problems, lung or breathing problems, liver problems, have had an organ transplant, or are pregnant or plan to become pregnant before starting treatment.

Opdivo received Priority Review and Orphan Drug designations for this indication. Priority Review designation directs overall attention and resources to the evaluation of applications for drugs that, if approved, would be significant improvements in the safety or effectiveness of the treatment, diagnosis or prevention of serious conditions when compared to standard applications. Breakthrough Therapy designation is a process designed to expedite the development and review of drugs that are intended to treat a serious condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on a clinically significant endpoint(s).

The FDA granted approval to Bristol-Myers Squibb Company.

This review was conducted under Project Orbis, an initiative of the FDA Oncology Center of Excellence. Project Orbis provides a framework for concurrent submission and review of oncology drugs among international partners. For this review, the FDA collaborated with the Australian Therapeutic Goods Administration, the Brazilian Health Regulatory Agency, Health Canada and Switzerland’s Swissmedic. The application reviews are ongoing at the other regulatory agencies.

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.”

For more information, please visit: FDA.gov

Materials above provided by the U.S. Food and Drug AdministrationNote: Content may be edited for style and length.

Source: The U.S. Food and Drug Administration. “FDA Approves First Immunotherapy for Initial Treatment of Gastric Cancer.” FDA News Release. U.S. Food and Drug Administration , 16 April 2021. <https://www.fda.gov/news-events/press-announcements/fda-approves-first-immunotherapy-initial-treatment-gastric-cancer>


Scott Dye Memorial Topgolf Tournament

April 14, 2021

The Scott Dye Memorial Topgolf Tournament will take place on Saturday, May 8, 2021 from 8:45 AM – 12:00 PM MST at Topgolf 6101 North 99th Avenue, Glendale, AZ 85305.  Register today! Click here.

The Dye Family. Photo via: Linda Dye

Linda, Michelle, Jennifer and Richard are coordinating the esophageal awareness event in memory of Scott E. Dye who passed away from stage IV Esophageal Cancer on December 13th, 2015.  This is their story:

“It seems like just yesterday that we found out our father was diagnosed with esophageal cancer. Our father went to the hospital for chest pain on November 13, 2015 and after the CAT scan was completed the doctors found a mass on his liver. That is when his primary doctor did more tests (endoscopy) and blood work. The results came back indicating esophageal cancer, Stage IV on November 30, 2015. Once the cancer was known there was nothing but vomiting, nausea and dehydration that came from it in the coming days and weeks. We were watching him quickly go downhill just days after he was diagnosed. During this time, a port was put in so that chemotherapy could start, and the goal was to FIGHT and beat this nightmare.

By December 9, 2015 he was transported back to the hospital due to a stomach hemorrhage. He was clinging to his life as his kidneys started to fail. Our father was placed in ICU and was too weak to start his chemotherapy. This was all happening too fast and we could not process that he was diagnosed with cancer let alone that he passed away on December 13, 2015, just a month after symptoms and a diagnosis was given. To see someone you love pass away in front of your eyes is the most unexplainable feeling you can have and you will remember it forever.
We wanted to find a way to help with funding and research. So, we have teamed up with The Salgi Esophageal Cancer Research Foundation as a way to raise awareness and remember our father, and to help others become aware of symptoms and early detection of cancer.”

The event aims to raise awareness, encourage early detection, and fund research esophageal cancer..in hopes of a cure! See below for more event information and to register, click here.

Scott Dye Memorial Topgolf Tournament

Saturday, May 8, 2021, 8:45 AM MST
Topgolf
6101 North 99th Avenue
Glendale, AZ 85305

Register today! Click here

Tournament player tickets are $99.00 and will have a chance to try for $10,000 ‘Hole in One’ contest. Tournament Top Contender game, Included: Lifetime Membership, swag bag, Raffle Prizes. Rain or shine, Fun for the whole family.  Spectators/Breakfast Buffet tickets are $55.00 and will receive a raffle ticket, fun mingling, and cheering on friends and family.  Registration is online only and ends on April 26th 2021. Register today! Click here.

EVENT TIMELINE:

8:45 am: Ambassador to greet guests in lobby, And Registration.

9:00 am: Topgolf play begins

9:30 am: Buffet is served for 90 minutes

11:30 am: Raffle Prizes

12:00 pm: Topgolf play concludes

Register today! Click here.

Share on Facebook! Click here.


Fundraising Spotlight: #PeriwinkleECStack Fundraising Stack Challenge

April 13, 2021

Carly, who goes by the handle @blairwitchbooks on Instagram, lost her father to esophageal cancer. During the month of April which is ‘Esophageal Cancer Awareness Month’, Carly will be hosting a fundraiser called the #PeriwinkleECStack challenge to benefit The Salgi Esophageal Cancer Research Foundation.

Read more below about her father and her fundraiser.

To participate in the Instagram challenge fundraiser, visit Carly on Instagram and use the hashtag #PeriwinkleECStack.

Image via Carly @blairwitchbooks


Today I’m sharing something personal and close to my heart. April is Esophageal Cancer Awareness month. 3.5 years ago I lost my father to it. I’d never heard anyone speak of esophageal cancer before my family was affected. Because of this, even with my tiny platform, I think it’s very important to spread awareness for the month of April.

For the month of April I will be hosting the #PeriwinkleECStack challenge to spread awareness & raise some funds! For every post that uses this hashtag & tags me, I will donate $1 FOR EVERY STACK to the Salgi Foundation for Esophageal Cancer Awareness & Research.

Some terrifying facts about EC:

Esophageal cancer has increased by 733% over the past 4 decades; making it among the fastest growing & deadliest cancers in the US & western world.

Chronic heartburn is a primary risk factor.

There are NO routine or standard screenings to detect esophageal cancer in the early stages.

Only 19.9% of patients diagnosed will survive 5(+) years. (My dad was diagnosed in October and passed the following September – not even a year.)

ESOPHAGEAL CANCER RESEARCH IS CRITICALLY UNDERFUNDED. Being such a fast-growing cancer – this should NOT be the case.

If I tagged you, please join me and participate by posting your periwinkle stack! If you see this – please consider yourself tagged as well! Post your periwinkle stacks – spread some awareness – and please tag me & #PeriwinkleECStack !

***facts from @salgifoundation


Fundraising Spotlight: Michelle’s Esophageal Cancer Awareness Pins and T-Shirts

March 25, 2021

Each year, April 30th marks the last day of Esophageal Cancer Awareness month.  In 2017, April 30th was also the date that Raymond John Glazer passed away from esophageal cancer.

Now his daughter Michelle is hosting a fundraiser in his memory. Michelle will be selling esophageal cancer awareness periwinkle tack pins and t-shirts on her website to benefit The Salgi Esophageal Cancer Research Foundation.

The esophageal cancer awareness periwinkle pins are $5 and the “Peace Love Cure Esophagus Cancer” t-shirts start at $18. Both are available on her website, please click here.

Please read below to learn more about her father’s story and how you can shop to make a difference.

Michelle’s Story, In Loving Memory of Raymond John Glazer:

“Esophageal cancer research is severely underfunded; there are currently no early screenings or any effective treatments for this very deadly disease!

My father developed a problem swallowing, which he never mentioned. He had been caring for our mother for 3 years post stroke at 80 years old. He cleaned her, changed her, fed her and checked her blood sugar, absolutely refusing to put his wife in a nursing home. We also noticed he was getting extremely thin, always had heartburn and was not eating much.

Then September 23rd, 2016, my sister took him to the hospital because he couldn’t even swallow water. He had an endoscopy with biopsy the next day. The doctor had the Oncologist meet with us the following day, telling us he had a golf ball sized tumor right above the stomach in his esophagus. The biopsy came back poorly differentiated high grade adenocarcinoma.

He agreed to the 4 months of radiation daily and chemo weekly, as what was recommended. I sat with him for hours every day at the hospital. He also made me his power of attorney if he could no longer make decisions for himself. The GI doctor placed a mesh stent in the esophagus to hold the tumor back which allowed him to eat and gain some strength before treatment started.

He became so sick from treatments and wasn’t eating, electrolytes were off and he was extremely confused. After discussing it with him, I signed to have a gastric tube placed in November. He could barely walk at this time, so we also got him a wheelchair. The doctor that placed the tube told me after surgery that the tumor was growing through the mesh. Last mega radiation was early December and he would have a CT with contrast in May.

On April 25th, I took him to the ER. He woke all sweaty, couldn’t breathe or talk well and could no longer stand on his own. I asked the admitting doctor if he could order the CT now, which he did. He called me to come in on April 27th, because Dad wasn’t doing well. He waited for me even after his shift was done to tell me that the CT showed the tumor had invaded straight across the abdomen, into the spinal cord, lungs, brain, prostate and hip. The absolute worst thing I had to do was inform the rest of my family and sign a Do Not Resuscitate, Do Not Intubate. Dad had told the doctor this was what he wanted.

On April 30th, he passed in his sleep at 4:40am, ironic that it was the last day of Esophageal Cancer Awareness month. I am raising funds for Salgi, as I did last year, in hopes of finding a way to test early and hopefully a treatment that works for those that become afflicted. All proceeds are being donated in memory of Raymond John Glazer.”

In memory of Raymond John Glazer

Click here to shop! 

Please join us in thanking Michelle by sharing this fundraiser and post with your family members, friends and on social media.  Thank you, Michelle!

Facebook: https://www.facebook.com/SalgiFoundation

Shop: https://shop.peacockorchid.com

Photos and story courtesy of Michelle Z. 


April is Esophageal Cancer Awareness Month

March 25, 2021

Esophageal cancer is one of the fastest and deadliest cancers in the United States, United Kingdom and other western countries. 

The Salgi Esophageal Cancer Research Foundation awarded two research grants! The first in 2015 and the second in 2018.  The research awarded in 2018, a breath test for esophageal cancer, is currently underway.  Both grants were given in honor of all the men and women affected by esophageal cancer. While these are tremendous accomplishments, esophageal cancer research is critically underfunded and medical researchers continuously inquire about funding.   

In addition, COVID-19 has greatly impacted or delayed screenings, diagnosis and treatments for many individuals who may now be facing advanced prognosis.  

Now more than ever, your support is critically needed to enable this charity to fulfill our mission.

Learn the Facts: 

-Esophageal cancer increased over 700% in the past four decades. 

-Esophageal cancer is one of the fastest growing cancers in the United States and western world. 

-Esophageal cancer has an overall 5 year survival rate of only 19.9%. 

-There are no routine or standard screenings. 

-Symptoms often arise late, once the cancer has spread. 

-Stage IV has a survival rate of only 4.8%. 

-Esophageal cancer research is critically underfunded. 

-In 2016, an estimated $1.6 billion was spent on esophageal cancer care in the United States. 

-2021 estimates for esophageal cancer: 19,260 diagnoses & 15,530 deaths.

2021 Infographic

Save the infographic below and share it on social media to help raise awareness. Tag us in your posts. @SalgiFoundation

Donate Today!

Donate today to our ‘April is Esophageal Cancer Awareness Month’ Facebook fundraiser! Facebook makes it easy to donate and share the campaign. 100% of all donations go directly towards our mission. Click the button or link below.

Facebook.com/donate/2846389948938533

“Awareness, early detection, research…in hopes of a CURE!™”


2021 Virtual Esophageal Cancer Walk/Run

March 18, 2021

We care about our community of supporters and our top priority is the health, safety and well being of our walkers, runners, volunteers and sponsors.

Due to the ongoing impact of the pandemic and the uncertainty surrounding events, our in-person Rhode Island and Colorado events are going to be virtual only again this year.

While we are still unable to gather in a large group, we can still make a big impact together!

.
Sign up today for the 2021 Virtual Esophageal Cancer Walk/Run.  The virtual event is open world-wide and will take place on Saturday, June 19th or Sunday, June 20th – your choice!
.
T-shirts are available for guests within the continental US for a limited time and children sizes are available, too!
.
  
.
.

There are two ticket options:

1. T-Shirt Ticket: $30 to participate in the virtual event AND receive a t-shirt. Children size t-shirts available.    Must register by Thursday, May 20, 2021 at 5 PM EST. T-shirts open to continental US only.

2. Virtual Ticket Only: $20 to participate in the virtual event only, no t-shirt. Must register by Friday, June 18, 2021 at 5 PM EST.

Sign up today! http://salgivirtualwalkrun2021.eventbrite.com

.
.
 
.
.
The virtual event can take place in your neighborhood, on a trail, bike path, track, by the ocean, sea, river or wherever you would like to walk or run. Walk, run, bicycle, roller-blade, skateboard, swim…the possibilities are endless! Since the virtual event is not timed, you are able to participate at your own pace, any distance and at any time either Saturday or Sunday. You may sign up as an individual or as a virtual team.
.
.
..
.
Whether you register or are unable to participate but would still like to make a difference, you can donate to the event.  Also, everyone can create an online, custom fundraising page to help make an even bigger impact.
.
If you have ever wanted to take part in one of our Esophageal Cancer events, now is your chance!
.
.

Thank You, In-Kind Sponsors!

LesserEvil Snacks   True Leaf Market

MaryRuth's Organics   Wholesome Sweet  Orgain

Baker Creek Heirloom Seeds
*While supplies last.

.
.

Whether you sign up, donate, create a fundraiser, sponsor, and/or spread the word, we appreciate your support.  Our events are a large part of our fundraising and awareness initiatives and we rely on the generosity of individuals and businesses in our communities to make them a success.  On behalf of The Salgi Esophageal Cancer Research Foundation, thank you!

.

To sign up and/or donate, visit: salgivirtualwalkrun2021.eventbrite.com

To create your own custom, fundraising page, visit: charity.gofundme.com/salgivirtualwalkrun2021

Please RSVP and share this event on Facebook: https://www.facebook.com/events/421726888914561

.
.
.
.
.
.
.
.
.

 


Fundraising Spotlight: Glendale, AZ: Scott Dye Memorial Topgolf Tournament

February 25, 2021

The Scott Dye Memorial Topgolf Tournament will take place on Saturday, May 8, 2021 from 8:45 AM – 12:00 PM MST at Topgolf 6101 North 99th Avenue, Glendale, AZ 85305.  Register today! Click here.

The Dye Family. Photo via: Linda Dye

Linda, Michelle, Jennifer and Richard are coordinating the esophageal awareness event in memory of Scott E. Dye who passed away from stage IV Esophageal Cancer on December 13th, 2015.  This is their story:

“It seems like just yesterday that we found out our father was diagnosed with esophageal cancer. Our father went to the hospital for chest pain on November 13, 2015 and after the CAT scan was completed the doctors found a mass on his liver. That is when his primary doctor did more tests (endoscopy) and blood work. The results came back indicating esophageal cancer, Stage IV on November 30, 2015. Once the cancer was known there was nothing but vomiting, nausea and dehydration that came from it in the coming days and weeks. We were watching him quickly go downhill just days after he was diagnosed. During this time, a port was put in so that chemotherapy could start, and the goal was to FIGHT and beat this nightmare.

By December 9, 2015 he was transported back to the hospital due to a stomach hemorrhage. He was clinging to his life as his kidneys started to fail. Our father was placed in ICU and was too weak to start his chemotherapy. This was all happening too fast and we could not process that he was diagnosed with cancer let alone that he passed away on December 13, 2015, just a month after symptoms and a diagnosis was given. To see someone you love pass away in front of your eyes is the most unexplainable feeling you can have and you will remember it forever.
We wanted to find a way to help with funding and research. So, we have teamed up with The Salgi Esophageal Cancer Research Foundation as a way to raise awareness and remember our father, and to help others become aware of symptoms and early detection of cancer.”

The event aims to raise awareness, encourage early detection, and fund research esophageal cancer..in hopes of a cure! See below for more event information and to register, click here.

 

Scott Dye Memorial Topgolf Tournament

Saturday, May 8, 2021, 8:45 AM MST
Topgolf
6101 North 99th Avenue
Glendale, AZ 85305
Register today! Click here

 

Tournament player tickets are $99.00 and will have a chance to try for $10,000 ‘Hole in One’ contest. Tournament Top Contender game, Included: Lifetime Membership, swag bag, Raffle Prizes. Rain or shine, Fun for the whole family.  Spectators/Breakfast Buffet tickets are $55.00 and will receive a raffle ticket, fun mingling, and cheering on friends and family.  Registration is online only and ends on April 26th 2021. Register today! Click here.

EVENT TIMELINE:

8:45 am: Ambassador to greet guests in lobby, And Registration.

9:00 am: Topgolf play begins

9:30 am: Buffet is served for 90 minutes

11:30 am: Raffle Prizes

12:00 pm: Topgolf play concludes

 

Register today! Click here.

Share on Facebook! Click here.


Late onset symptoms attribute to lethal esophageal cancer

February 23, 2021

Esophageal cancer is often detected in later stages, as symptoms often arise too late, once the cancer spreads. There are no standard or routine screenings to detect esophageal cancer in its earliest stages, when the cancer is more treatable. Paired with late onset of symptoms, cancer of the esophagus is highly aggressive and unfortunately, for many, a lethal diagnosis.

Unlike other cancers which can sometimes show early warning signs, esophageal cancer typically does not have any obvious symptoms in the early stages, when the cancer is in the esophagus and has not spread to other organs or lymph nodes.

Symptoms of esophageal cancer include:

Dysphagia (difficulty swallowing)
Chronic heartburn or indigestion
Frequent choking while eating
Chest pain, pressure or burning
Unexplained weight loss
Cough or hoarseness
Vomiting
Coughing up blood
Family history of esophageal cancer.

The most common of the symptoms listed above is difficulty swallowing. Dysphagia is the medical term for the symptom of difficulty swallowing, “This is usually a progressive problem, which means that it initially begins when large pieces of food are not chewed thoroughly before swallowing, but then the problem can become much worse to the point where liquids can’t be swallowed easily.”

Any of the symptoms listed above should be taken seriously and you should consult with a physician. Symptoms should never be ignored or overlooked. Do not solely rely on information retrieved from the internet or other sources.

Early detection of esophageal cancer saves lives!

There are more treatment options available for early stage diagnoses of esophageal cancer. There is also a better chance of survival and recovery when the cancer is detected in the early stages, as the cancer is still relatively small and is less likely to have metastasized (spread to other organs or areas in the body).  Tests are necessary to detect if there is a growth in the esophagus and to see what is causing symptoms.  Learn more about how esophageal cancer is diagnosed. 

 

 

The Salgi Esophageal Cancer Research Foundation is a 501 (c) (3) non profit organization as recognized by the Internal Revenue Service.

Content found on Salgi.org is for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

 

Sources:

Management of Barrett’s oesophagus and intramucosal oesophageal cancer: a review of recent development National Center for Biotechnology Information,S. National Library of Medicine. Bethesda MD, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437535
 
Esophageal Cancer Research Funding: “A Snapshot of Esophageal Cancer” http://www.cancer.gov/researchandfunding/snapshots/esophageal

Key Statistics for Esophageal Cancer, The American Cancer Society https://www.cancer.org/cancer/esophagus-cancer/about/key-statistics.html 

Department of Health and Human Services, Centers for Disease Control and Prevention,cdc.gov 
 
National Cancer Institute, Surveillance, Epidemiology and End Results Program, seer.cancer.gov 
 
Esophageal Cancer On The Rise, webmd.com
 
National Cancer Institute: PDQ® Esophageal Cancer Treatment. Bethesda, MD: National Cancer Institute. cancer.gov
 
Gastroenterology & Endoscopy News, GastroEndoNews.com